Martin R Stockler

Martin R Stockler

UNVERIFIED PROFILE

Are you Martin R Stockler?   Register this Author

Register author
Martin R Stockler

Martin R Stockler

Publications by authors named "Martin R Stockler"

Are you Martin R Stockler?   Register this Author

99Publications

1757Reads

40Profile Views

Patient-reported outcomes and localized prostate cancer management.

Nat Rev Urol 2020 Mar 18. Epub 2020 Mar 18.

NHMRC Clinical Trials Centre, The University of Sydney, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41585-020-0303-2DOI Listing
March 2020

Survival and cardiac toxicity in patients with HER2-positive, metastatic breast cancer treated with trastuzumab in routine clinical practice.

Asia Pac J Clin Oncol 2020 Feb 28;16(1):34-38. Epub 2019 Oct 28.

NHMRC Clinical Trials Centre, University of Sydney, Camperdown, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ajco.13280DOI Listing
February 2020

Preferences for Immunotherapy in Melanoma: A Systematic Review.

Ann Surg Oncol 2020 Feb 29;27(2):571-584. Epub 2019 Oct 29.

NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-019-07963-yDOI Listing
February 2020

Enzalutamide in Metastatic Prostate Cancer. Reply.

N Engl J Med 2019 10;381(15):1494-1495

Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1910553DOI Listing
October 2019

Serum Free Methylated Glutathione S-transferase 1 DNA Levels, Survival, and Response to Docetaxel in Metastatic, Castration-resistant Prostate Cancer: Post Hoc Analyses of Data from a Phase 3 Trial.

Eur Urol 2019 Sep 19;76(3):306-312. Epub 2018 Nov 19.

Chris O'Brien Lifehouse, Sydney, Australia; Garvan Institute of Medical Research, Sydney, Australia; University of NSW, Sydney, Australia; University of Sydney, Sydney, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2018.11.001DOI Listing
September 2019

Estimating survival time in older adults receiving chemotherapy for advanced cancer.

J Geriatr Oncol 2019 Sep 6. Epub 2019 Sep 6.

Concord Cancer Centre, Concord Repatriation General Hospital, Sydney, Australia; University of Sydney, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jgo.2019.08.013DOI Listing
September 2019

Community views on factors affecting medicines resource allocation: cross-sectional survey of 3080 adults in Australia.

Aust Health Rev 2019 Jul;43(3):254-260

National Health and Medical Research Council (NHMRC) Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1071/AH16209DOI Listing
July 2019

Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer.

N Engl J Med 2019 07 2;381(2):121-131. Epub 2019 Jun 2.

From Monash University (I.D.D., M.F., D.W.P.), Eastern Health (I.D.D.), Australian Urology Associates (M.F.), Monash Health (D.W.P.), and the Peter MacCallum Cancer Centre and the University of Melbourne (S.K.S., S.G.W.), Melbourne, VIC, the National Health and Medical Research Council Clinical Trials Centre, University of Sydney (A.J.M., M.R.S., X.C., W.E.H., E.T., S.Y., A.Y.Z.), the Chris O'Brien Lifehouse (M.R.S., L.G.H., A.Y.Z.), the University of Sydney (L.G.H., G.M.), Royal Prince Alfred Hospital (L.G.H.), Kinghorn Cancer Centre, St. Vincent's Hospital, and Garvan Institute of Medical Research (A.M.J.), Macquarie University (A.Y.Z.), and Western Sydney University (R.R.Z.), Sydney, Concord Cancer Centre, Concord Repatriation General Hospital, Concord, NSW (M.R.S.), Port Macquarie Base Hospital and Mid North Coast Cancer Institute Port Macquarie, Port Macquarie, NSW (S.B.), Sydney Adventist Hospital, Wahroonga, NSW (G.M.), the ANZUP Cancer Trials Group, Camperdown, NSW (M.M.), the Adelaide Cancer Centre and the University of Adelaide (F.P.) and the Royal Adelaide Hospital (T.H.T.), Adelaide, SA, and Orange Health Service, Central West Cancer Care Centre, Orange, NSW (R.R.Z.) - all in Australia; BC Cancer and the University of British Columbia, Vancouver (K.N.C.), the Cross Cancer Institute and the University of Alberta, Edmonton (S.A.N.), Canadian Cancer Trials Group, Queen's University (W.P., F.V.-B.), and the Kingston Health Sciences Center (F.V.-B.), Kingston, ON, and the University of Ottawa and the Ottawa Hospital Research Institute, Ottawa (M.N.R.) - all in Canada; Guy's and St. Thomas' NHS Foundation Trust Biomedical Research Centre, Cancer Research UK and King's College London, and Sarah Cannon Research UK, London (S.C.), and the Royal Cornwall Hospital, Truro (A. Thomson) - all in the United Kingdom; Auckland City Hospital, Auckland (N.J.L.), and the Waikato District Health Board, Hamilton (A. Tan) - both in New Zealand; Cancer Trials Ireland (J.M., R.M.), Mater Misericordiae University Hospital (J.M.), and St. Vincent's University Hospital and University College Dublin (R.M.D.) - all in Dublin; and Dana-Farber Cancer Institute and Harvard Medical School (C.J.S.) - both in Boston.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1903835DOI Listing
July 2019

Discussing Prognosis, Preferences, and End-of-Life Care in Advanced Cancer: We Need to Speak.

JAMA Oncol 2019 06;5(6):788-789

National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Camperdown NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2019.0291DOI Listing
June 2019

Accentuating the Positive: Do Trials Give Unrealistic Expectations of Long-Term Survival?

JNCI Cancer Spectr 2019 Jun 15;3(2):pkz018. Epub 2019 Apr 15.

NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jncics/pkz018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6649770PMC
June 2019

Predicting chemotherapy toxicity in older adults: Comparing the predictive value of the CARG Toxicity Score with oncologists' estimates of toxicity based on clinical judgement.

J Geriatr Oncol 2019 03 14;10(2):202-209. Epub 2018 Sep 14.

Concord Cancer Centre, Concord Repatriation General Hospital, Sydney, Australia; University of Sydney, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jgo.2018.08.010DOI Listing
March 2019

Oncologists' perceptions on the usefulness of geriatric assessment measures and the CARG toxicity score when prescribing chemotherapy for older patients with cancer.

J Geriatr Oncol 2019 03 28;10(2):210-215. Epub 2018 Nov 28.

Concord Cancer Centre, Concord Repatriation General Hospital, Sydney, Australia; University of Sydney, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jgo.2018.11.004DOI Listing
March 2019

Patient-reported Outcomes in Metastatic Castration-sensitive Prostate Cancer in the Adjuvant Setting.

Eur Urol Focus 2019 03 3;5(2):144-146. Epub 2019 Jan 3.

NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euf.2018.12.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6658671PMC
March 2019

Medicinal cannabis for chemotherapy-induced nausea and vomiting: prescribing with limited evidence.

Med J Aust 2019 01 28;210(1):11-12.e1. Epub 2018 Dec 28.

NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5694/mja17.01099DOI Listing
January 2019

A randomised controlled trial of an advance care planning intervention for patients with incurable cancer.

Br J Cancer 2018 11 29;119(10):1182-1190. Epub 2018 Oct 29.

Centre for Medical Psychology and Evidence-based Decision-making (CeMPED), School of Psychology and Department of Medicine, University of Sydney, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41416-018-0303-7
Publisher Site
http://dx.doi.org/10.1038/s41416-018-0303-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251033PMC
November 2018

Medicinal cannabis for chemotherapy-induced nausea and vomiting: prescribing with limited evidence.

Med J Aust 2018 Nov 12. Epub 2018 Nov 12.

NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW.

View Article

Download full-text PDF

Source
November 2018

Effect Sizes Hypothesized and Observed in Contemporary Phase III Trials of Targeted and Immunological Therapies for Advanced Cancer.

JNCI Cancer Spectr 2018 Oct 27;2(4):pky037. Epub 2018 Nov 27.

NHMRC Clinical Trials Centre, University of Sydney, Camperdown, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jncics/pky037DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6649714PMC
October 2018

Bisphosphonates and other bone agents for breast cancer.

Cochrane Database Syst Rev 2017 10 30;10:CD003474. Epub 2017 Oct 30.

Medical Oncology, Chris O'Brien Lifehouse, 119-143 Missenden Rd, Camperdown, Sydney, NSW, Australia, 2050.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/14651858.CD003474.pub4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485886PMC
October 2017

Screen Failure Rates in Contemporary Randomized Clinical Phase II/III Therapeutic Trials in Genitourinary Malignancies.

Clin Genitourin Cancer 2017 Sep 8. Epub 2017 Sep 8.

Princess Margaret Cancer Centre, Toronto, Ontario, Canada. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15587673173027
Publisher Site
http://dx.doi.org/10.1016/j.clgc.2017.08.019DOI Listing
September 2017

Societal perspective on access to publicly subsidised medicines: A cross sectional survey of 3080 adults in Australia.

PLoS One 2017 1;12(3):e0172971. Epub 2017 Mar 1.

National Health and Medical Research Council (NHMRC) Clinical Trials Centre, The University of Sydney, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0172971PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5332102PMC
August 2017

Discussing and prescribing expensive unfunded anticancer drugs in Australia.

ESMO Open 2017 21;2(2):e000170. Epub 2017 Jun 21.

NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/esmoopen-2017-000170DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519793PMC
June 2017

Is it all about price? Why requests for government subsidy of anticancer drugs were rejected in Australia.

Intern Med J 2017 Apr;47(4):400-407

NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/imj.13350DOI Listing
April 2017

Phase 2 study of circulating microRNA biomarkers in castration-resistant prostate cancer.

Br J Cancer 2017 Apr 9;116(8):1002-1011. Epub 2017 Mar 9.

Cancer Division, The Kinghorn Cancer Centre/Garvan Institute of Medical Research, Darlinghurst, New South Wales 2010, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/bjc.2017.50DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5396108PMC
April 2017

Mindfulness-Based Cognitive Therapy in Advanced Prostate Cancer: A Randomized Controlled Trial.

J Clin Oncol 2017 Jan 21;35(3):291-297. Epub 2016 Nov 21.

Suzanne K. Chambers, Stefano Occhipinti, Melissa Legg, and David P. Smith, Griffith University, Gold Coast; Suzanne K. Chambers, Samantha Clutton, Melissa Legg, Cancer Council Queensland; Robert A. Gardiner, University of Queensland, Brisbane; Suzanne K. Chambers, University of Southern Queensland, Toowoomba, Queensland; Suzanne K. Chambers, Prostate Cancer Foundation of Australia; Suzanne K. Chambers, Stefano Occhipinti, Samantha Clutton, Melissa Legg, Martin Berry, Martin R. Stockler, Mark Frydenberg, Robert A. Gardiner, Ian D. Davis, and David P. Smith, Australian and New Zealand Urogenital and Prostate Cancer Trials Group; Elizabeth Foley, Mind Potential; Martin R. Stockler, and David P. Smith, University of Sydney; David P. Smith, Cancer Council New South Wales, Sydney; Martin Berry, Central Coast Cancer Centre, Gosford; Martin R. Stockler, Concord Repatriation General Hospital, Concord, New South Wales; Suzanne K. Chambers, Robert A. Gardiner, Edith Cowan University, Perth, Western Australia; Mark Frydenberg, Monash Health; Mark Frydenberg, Ian D. Davis, Monash University; Ian D. Davis, Eastern Health, Melbourne, Victoria, Australia; and Stephen J. Lepore, Temple University, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://clf1.medpagetoday.com/content/pdf/reading-room/asco/J
Web Search
http://dx.doi.org/10.1200/JCO.2016.68.8788DOI Listing
January 2017

Design, implementation and reporting strategies to reduce the instance and impact of missing patient-reported outcome (PRO) data: a systematic review.

BMJ Open 2016 06 15;6(6):e010938. Epub 2016 Jun 15.

Central Clinical School, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia Psycho-oncology Co-operative Research Group, School of Psychology, University of Sydney, Sydney, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bmjopen-2015-010938DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916640PMC
June 2016

Valuing the benefits of new anticancer drugs.

Med J Aust 2016 Jun;204(11):403-5

NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5694/mja15.01362DOI Listing
June 2016

Patients' preferred and perceived roles in making decisions about adjuvant chemotherapy for non-small-cell lung cancer.

Lung Cancer 2016 May 21;95:8-14. Epub 2016 Feb 21.

Concord Cancer Centre, Sydney Australia; University of Sydney, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2016.02.009DOI Listing
May 2016

What is access to radiation therapy? A conceptual framework and review of influencing factors.

Aust Health Rev 2016 Feb;40(1):11-18

The Sydney Medical School, The University of Sydney, Sydney, NSW 2006, Australia. Email.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1071/AH14262DOI Listing
February 2016

Barriers to radiotherapy utilisation in New South Wales Australia: Health professionals' perceptions of impacting factors.

J Med Imaging Radiat Oncol 2015 Aug 15;59(4):535-41; quiz 542-4. Epub 2015 Jun 15.

Central Clinical School, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/1754-9485.12334DOI Listing
August 2015

Regional variation in identified cancer care needs of early-career oncologists in China, India, and Pakistan.

Oncologist 2015 May 17;20(5):532-8. Epub 2015 Apr 17.

Duke Cancer Institute, Department of Surgery, Department of Pathology, and Department of Immunology, Duke University Medical Center, Durham, North Carolina, USA; Department of Oncology, Allama Iqbal Medical College, Lahore, Pakistan; Department of Surgical Oncology, Tata Memorial Hospital, Mumbai, India; Clinical Trials Unit, Aga Khan University, Karachi, Pakistan; Capital Medical University Cancer Center, Beijing, People's Republic of China; National Health and Medical Research Council Clinical Trials Centre, Royal Prince Alfred and Concord Hospitals, University of Sydney, Sydney, New South Wales, Australia; Department of Precision Oncology, Asian Institute of Oncology, Sion, Mumbai, India; Duke Global Health Institute, Duke University, Durham, North Carolina, USA; Department of Medical Oncology, Tata Medical Center, Kolkata, India; Research Triangle Institute, Research Triangle Park, North Carolina, USA; Flatiron Health, New York, New York, USA.

View Article

Download full-text PDF

Source
http://theoncologist.alphamedpress.org/cgi/doi/10.1634/theon
Publisher Site
http://dx.doi.org/10.1634/theoncologist.2014-0213DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425376PMC
May 2015

Factors influencing the use of RT in NSW: a qualitative study exploring consumer and health professional perspectives.

J Med Imaging Radiat Oncol 2014 Oct 19;58(5):625-32. Epub 2014 Jun 19.

The Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia; Sydney Cancer Centre, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia; Central Coast Cancer Centre, Gosford Hospital, Sydney, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/1754-9485.12198DOI Listing
October 2014

Development of the measure of ovarian symptoms and treatment concerns: aiming for optimal measurement of patient-reported symptom benefit with chemotherapy for symptomatic ovarian cancer.

Int J Gynecol Cancer 2014 Jun;24(5):865-73

*School of Psychology and Psycho-Oncology Cooperative Research Group (PoCoG), University of Sydney, Sydney, NSW, Australia; and †ANZGOG, Sydney, NSW, Australia and NHMRC Clinical Trials Centre, University of Sydney, University of Sydney, Sydney, NSW, Australia; ‡Princess Margaret Hospital, Toronto, Ontario, Canada; and §School of Nursing, University of Pittsburgh, Pittsburgh, PA.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/ijgc/2014/06000/Development_of_
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/IGC.0000000000000167DOI Listing
June 2014

Patient-reported outcome results from the open-label phase III AURELIA trial evaluating bevacizumab-containing therapy for platinum-resistant ovarian cancer.

J Clin Oncol 2014 May 31;32(13):1309-16. Epub 2014 Mar 31.

Martin R. Stockler, Madeleine T. King, Chee Khoon Lee, The University of Sydney; Michael Friedlander, Prince of Wales Clinical School, University of New South Wales, Sydney, Australia; Felix Hilpert, Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) and Klinik für Gynäkologie und Geburtshilfe, Kiel; Nikolaus de Gregorio, AGO and University of Ulm Medical Center, Ulm, Germany; Lari Wenzel, University of California Irvine, Irvine, CA; Florence Joly, Group d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO) and Centre François Baclesse, Caen; Eric Pujade-Lauraine, GINECO and Centre Hospitalier Universitaire Hotel Dieu, Paris, France; José Angel Arranz, Grupo Español de Investigación en Cáncer de Ovario and Hospital General Universitario Gregorio Marañón, Madrid, Spain; Mansoor Raza Mirza, Nordic Society of Gynaecological Oncology and Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Roberto Sorio, Multicenter Italian Trials in Ovarian Cancer and Centro di Riferimento Oncologico-Istituto di Ricovero e Cura a Carattere Scientifico, Aviano, Italy; and Ulrich Freudensprung, Vesna Sneller, Gill Hales, F. Hoffmann-La Roche, Basel, Switzerland.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2014/03/28/JCO.2013.51
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2013.51.4240
Publisher Site
http://dx.doi.org/10.1200/JCO.2013.51.4240DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876313PMC
May 2014

The median informs the message: accuracy of individualized scenarios for survival time based on oncologists' estimates.

J Clin Oncol 2013 Oct 3;31(28):3565-71. Epub 2013 Sep 3.

Belinda E. Kiely, Andrew J. Martin, and Martin R. Stockler, National Health and Medical Research Council Clinical Trials Centre, University of Sydney; Belinda E. Kiely, Martin H.N. Tattersall, Nicholas R.C. Wilcken, Philip J. Beale, and Martin R. Stockler, Sydney Medical School, University of Sydney; Belinda E. Kiely, Martin H.N. Tattersall, Philip J. Beale, and Martin R. Stockler, Sydney Cancer Centre-Royal Prince Alfred and Concord Hospitals, Sydney; David Goldstein, Prince of Wales Hospital Clinical School, University of New South Wales, Kensington; Nicholas R.C. Wilcken, Westmead Hospital, Westmead; Ehtesham A. Abdi, Tweed Hospital, Tweed Heads; Amanda Glasgow, Wollongong Hospital, Wollongong, New South Wales; Anna K. Nowak, School of Medicine and Pharmacology, University of Western Australia, Crawley; Anna K. Nowak, Sir Charles Gardner Hospital, Nedlands, Western Australia; David K. Wyld, Royal Brisbane and Women's Hospital, Brisbane, Queensland; Michael Jefford, Peter MacCallum Cancer Centre; Michael Jefford, University of Melbourne, Melbourne, Victoria, Australia; and Paul A. Glare, Memorial Sloan-Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.44.7821DOI Listing
October 2013

A phase II clinical trial of the vascular disrupting agent BNC105P as second line chemotherapy for advanced Malignant Pleural Mesothelioma.

Lung Cancer 2013 Sep 17;81(3):422-427. Epub 2013 Jun 17.

NHMRC Clinical Trials Centre, University of Sydney, Medical Foundation Building, 92-94 Parramatta Road, Camperdown, NSW 2050, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2013.05.006DOI Listing
September 2013

Patterns of management and surveillance imaging amongst medical oncologists in Australia for stage I testicular cancer.

BJU Int 2013 Jul;112(2):E35-43

Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group Ltd, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bju.12221DOI Listing
July 2013

Risk assessment to guide prostate cancer screening decisions: a cost-effectiveness analysis.

Med J Aust 2013 Jun;198(10):546-50

NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5694/mja12.11597DOI Listing
June 2013

Intravesical chemotherapy plus bacille Calmette-Guérin in non-muscle invasive bladder cancer: a systematic review with meta-analysis.

BJU Int 2013 May 17;111(6):977-83. Epub 2012 Dec 17.

National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1464-410X.2012.11390.xDOI Listing
May 2013

ACP Journal Club. Intermittent and continuous androgen deprivation did not differ for mortality after radiotherapy for prostate cancer.

Ann Intern Med 2013 Jan;158(2):JC9

University of Sydney, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7326/0003-4819-158-2-201301150-02009DOI Listing
January 2013

Why is management of cancer pain still a problem?

J Clin Oncol 2012 Jun 16;30(16):1907-8. Epub 2012 Apr 16.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2011.41.3146DOI Listing
June 2012

ACP Journal Club. Individual patient meta-analysis: taxane plus anthracycline reduces mortality from early breast cancer.

Ann Intern Med 2012 Jun;156(12):JC6-4

Westmead Hospital, Sydney Cancer Centre and NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7326/0003-4819-156-12-201206190-02004DOI Listing
June 2012

Patient-reported outcomes of prostate high-dose-rate brachytherapy boost comparing an outpatient and inpatient protocol: a two-center chronologic cohort study.

Brachytherapy 2011 Nov-Dec;10(6):454-60. Epub 2011 May 6.

Department of Radiation Oncology, Sydney Cancer Centre, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S153847211100269
Publisher Site
http://dx.doi.org/10.1016/j.brachy.2011.03.002DOI Listing
February 2012

Bisphosphonates and other bone agents for breast cancer.

Cochrane Database Syst Rev 2012 Feb 15(2):CD003474. Epub 2012 Feb 15.

Department of Medical Oncology, Royal North Shore Hospital, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/14651858.CD003474.pub3DOI Listing
February 2012

Patients' experiences of high-dose-rate brachytherapy boost for prostate cancer using an inpatient protocol.

Brachytherapy 2011 Sep-Oct;10(5):395-400. Epub 2011 Feb 23.

Department of Radiation Oncology, Sydney Cancer Centre, Royal Prince Hospital, Sydney, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.brachy.2011.01.008DOI Listing
January 2012

Need for global partnership in cancer care: perceptions of cancer care researchers attending the 2010 australia and Asia pacific clinical oncology research development workshop.

J Oncol Pract 2011 Sep 4;7(5):324-9. Epub 2011 Aug 4.

Duke Comprehensive Cancer Center; Department of Surgery; Department of Medicine, Division of Medical Oncology, Duke University Medical Center, Durham NC; Discipline of Palliative and Supportive Services; Department of Medical Oncology, Flinders Medical Centre, Flinders University, Adelaide; National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Camperdown; Sydney Cancer Centre, Royal Prince Alfred and Concord Hospitals, Sydney, Australia; Allama Iqbal Medical College, Lahore, Pakistan; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India; NCIC Clinical Trials Group, Kingston, Ontario, Canada.

View Article

Download full-text PDF

Source
http://jop.ascopubs.org/site/er/JOP000230.pdf
Web Search
http://jop.ascopubs.org/cgi/doi/10.1200/JOP.2011.000230
Publisher Site
http://dx.doi.org/10.1200/JOP.2011.000230DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3170067PMC
September 2011

Thinking and talking about life expectancy in incurable cancer.

Semin Oncol 2011 Jun;38(3):380-5

NHMRC Clinical Trials Centre, University of Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2011.03.007DOI Listing
June 2011

Deriving a patient-based utility index from a cancer-specific quality of life questionnaire.

Value Health 2009 Jul-Aug;12(5):800-7

NHMRC Clinical Trials Centre, University of Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1524-4733.2009.00505.xDOI Listing
May 2011

Lung cancer clinicians' preferences for adjuvant chemotherapy in non-small-cell lung cancer: what makes it worthwhile?

Lung Cancer 2011 May;72(2):213-8

NHMRC Clinical Trials Centre, University of Sydney, Locked Bag 77, Camperdown, NSW 1450, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2010.08.007DOI Listing
May 2011

Life after adjuvant chemotherapy for breast cancer: the news is mostly good.

J Clin Oncol 2011 Mar 7;29(9):1092-3. Epub 2011 Feb 7.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2010.33.5588DOI Listing
March 2011

How long have I got? Estimating typical, best-case, and worst-case scenarios for patients starting first-line chemotherapy for metastatic breast cancer: a systematic review of recent randomized trials.

J Clin Oncol 2011 Feb 28;29(4):456-63. Epub 2010 Dec 28.

National Health and Medical Research Council Clinical Trials Centre and Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2010.30.2174DOI Listing
February 2011

Are cancer drugs less likely to be recommended for listing by the Pharmaceutical Benefits Advisory Committee in Australia?

Pharmacoeconomics 2010 ;28(6):463-75

Sydney School of Public Health, University of Sydney, Sydney, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2165/11533000-000000000-00000DOI Listing
August 2010

Patients' preferences for chemotherapy in non-small-cell lung cancer: a systematic review.

Lung Cancer 2010 Aug 31;69(2):141-7. Epub 2010 May 31.

NHMRC Clinical Trials Centre, University of Sydney, Locked Bag 77, Camperdown, NSW 1450, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2010.05.001DOI Listing
August 2010

Comparison of two standard chemotherapy regimens for good-prognosis germ cell tumors: updated analysis of a randomized trial.

J Natl Cancer Inst 2010 Aug 14;102(16):1253-62. Epub 2010 Jul 14.

Sydney Cancer Centre, Gloucester House 6, Royal Prince Alfred Hospital, Missenden Rd, Camperdown, NSW 2050, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djq245DOI Listing
August 2010

Certain death in uncertain time: informing hope by quantifying a best case scenario.

J Clin Oncol 2010 Jun 20;28(16):2802-4. Epub 2010 Apr 20.

National Health and Medical Research Council Clinical Trials Centre, Camperdown, New South Wales 1450, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2009.27.3326DOI Listing
June 2010

Meta-analysis provides evidence-based effect sizes for a cancer-specific quality-of-life questionnaire, the FACT-G.

J Clin Epidemiol 2010 Mar 27;63(3):270-81. Epub 2009 Aug 27.

Quality of Life Office, Psycho-oncology Co-operative Research Group, School of Psychology, University of Sydney, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jclinepi.2009.05.001DOI Listing
March 2010

Preliminary validation of an optimally weighted patient-based utility index by application to randomized trials in breast cancer.

Value Health 2009 Sep 16;12(6):967-76. Epub 2009 Mar 16.

NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S109830151060297
Publisher Site
http://dx.doi.org/10.1111/j.1524-4733.2009.00536.xDOI Listing
September 2009

Students' PEARLS: successfully incorporating evidence-based medicine in medical students' clinical attachments.

Evid Based Med 2009 Aug;14(4):98-9

University of Sydney, Sydney, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/ebm.14.4.98-aDOI Listing
August 2009

Screening for prostate cancer: explaining new trial results and their implications to patients.

Med J Aust 2009 Aug;191(4):226-9

University of Sydney, Sydney Cancer Centre, Royal Prince Alfred Hospital, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
August 2009

Duration of chemotherapy for advanced non-small-cell lung cancer: a systematic review and meta-analysis of randomized trials.

J Clin Oncol 2009 Jul 26;27(20):3277-83. Epub 2009 May 26.

Sydney Cancer Center, Royal Prince Alfred Hospital, National Health and Medical Research Council Clinical Trials Centre, University of Sydney, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2008.19.4522DOI Listing
July 2009

Comparing patients' and their partners' preferences for adjuvant chemotherapy in early breast cancer.

Patient Educ Couns 2008 Aug 22;72(2):239-45. Epub 2008 Apr 22.

NHMRC Clinical Trials Centre, University of Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pec.2008.02.021DOI Listing
August 2008

Quality of life and adjuvant systemic therapy for early-stage breast cancer.

Expert Rev Anticancer Ther 2007 Aug;7(8):1123-34

NHMRC Clinical Trials Centre, Building M02F, University of Sydney, NSW 2006, Australia.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1586/14737140.7.8.112
Publisher Site
http://dx.doi.org/10.1586/14737140.7.8.1123DOI Listing
August 2007

Predicting the toxicity of weekly docetaxel in advanced cancer.

Clin Pharmacokinet 2006 ;45(6):611-22

Department of Pharmacology, University of Sydney, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.2165/00003088-200645
Web Search
http://dx.doi.org/10.2165/00003088-200645060-00004DOI Listing
November 2006

Prognostic factors in patients with recently diagnosed incurable cancer: a systematic review.

Support Care Cancer 2006 Oct 18;14(10):999-1011. Epub 2006 May 18.

Sydney Cancer Centre, Royal Prince Alfred Hospital, Missenden Road, Camperdown, NSW, 2050, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-006-0079-9DOI Listing
October 2006

Health status rated with the Medical Outcomes Study 36-Item Short-Form Health Survey after spinal cord injury.

Arch Phys Med Rehabil 2005 Dec;86(12):2290-5

Dept of Aged Care and Rehabilitation Medicine, Royal North Shore Hospital, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.apmr.2005.07.293DOI Listing
December 2005

Measuring men's opinions of prostate needle biopsy.

ANZ J Surg 2005 Aug;75(8):662-4

Concord Prostate Centre, Concord Hospital, Sydeny, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1445-2197.2005.03477.xDOI Listing
August 2005

Use of tamoxifen in advanced-stage hepatocellular carcinoma. A systematic review.

Cancer 2005 Apr;103(7):1408-14

National Health and Medical Research Council (NHMRC) Clinical Trials Centre, University of Sydney, Camperdown, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.20963DOI Listing
April 2005

Achieving equal standards in medical student education: is a national exit examination the answer?

Med J Aust 2005 Mar;182(5):228-30

Medical Oncology, Flinders Medical Centre, Flinders Drive, Bedford Park, SA 5042, Australia.

View Article

Download full-text PDF

Source
March 2005

The benefits and costs of tamoxifen for breast cancer prevention.

Aust N Z J Public Health 2003 ;27(1):34-40

National Health and Medical Research Council, Clinical Trials Centre, University of Sydney, Locked Bag 77, Camperdown NSW, 1450.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1467-842x.2003.tb00377.xDOI Listing
January 2004

Fulvestrant: spreading the word, but not too thinly.

Lancet 2003 Oct;362(9392):1254

NSW Breast Cancer Institute and Department of Medical Oncology, Westmead Hospital, NSW, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(03)14616-8DOI Listing
October 2003